Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1989-7-13
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0452-3458
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1291-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3249843-Antineoplastic Agents,
pubmed-meshheading:3249843-Cell Transformation, Neoplastic,
pubmed-meshheading:3249843-DNA, Neoplasm,
pubmed-meshheading:3249843-Drug Evaluation,
pubmed-meshheading:3249843-Flow Cytometry,
pubmed-meshheading:3249843-Humans,
pubmed-meshheading:3249843-Neoplasms,
pubmed-meshheading:3249843-Ploidies,
pubmed-meshheading:3249843-Prognosis
|
pubmed:year |
1988
|
pubmed:articleTitle |
[Clinical application of flow cytometry in lung cancer].
|
pubmed:publicationType |
Journal Article
|